We are live on ! Find out more
PSC

Prentiss Smith & Co Portfolio holdings

AUM $172M
1-Year Est. Return 21.18%
This Fund
S&P 500
This Quarter Est. Return
+0.28%
1 Year Est. Return
+21.18%
3 Year Est. Return
+55.24%
5 Year Est. Return
+52.07%
10 Year Est. Return
+229.25%
AUM
$178M
AUM Growth
+$3.96M
Cap. Flow
+$3.88M
Cap. Flow %
2.18%
Top 10 Hldgs %
48.24%
Holding
337
New
14
Increased
29
Reduced
64
Closed
64

Top Buys

Rank Stock Value
1
WSM icon
Williams-Sonoma
WSM
+$8.22M
2
ABT icon
Abbott
ABT
+$6.56M
3
MGA icon
Magna International
MGA
+$6.03M
4
FSLR icon
First Solar
FSLR
+$4.54M
5
FDX icon
FedEx
FDX
+$2.54M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$9.75M
2
TWX
Time Warner Inc
TWX
+$4.93M
3
XRX icon
Xerox
XRX
+$4.7M
4
PG icon
Procter & Gamble
PG
+$2.18M
5
SYK icon
Stryker
SYK
+$1.34M

Sector Composition

Rank Sector Weight
1 Healthcare 24.65%
2 Technology 15.82%
3 Consumer Discretionary 14.21%
4 Financials 12.71%
5 Industrials 10.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORCL icon
201
Oracle
ORCL
$331B
$9K 0.01%
221
– –
VCSH icon
202
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$9K 0.01%
117
– –
WPM icon
203
Wheaton Precious Metals
WPM
$50.6B
$9K 0.01%
400
– –
CAJ
204
DELISTED
Canon, Inc.
CAJ
$9K 0.01%
300
– –
IF
205
DELISTED
Aberdeen Indonesia Fund
IF
$9K 0.01%
1,400
– –
COP icon
206
ConocoPhillips
COP
$147B
$8K ﹤0.01%
192
– –
EMN icon
207
Eastman Chemical
EMN
$7.8B
$8K ﹤0.01%
116
-34
-23% -$2.5K
FISV
208
Fiserv Inc
FISV
$27.2B
$8K ﹤0.01%
150
– –
GILD icon
209
Gilead Sciences
GILD
$161B
$8K ﹤0.01%
100
-530
-84% -$47K
RMD icon
210
ResMed
RMD
$28.3B
$8K ﹤0.01%
125
– –
SRPT icon
211
Sarepta Therapeutics
SRPT
$1.66B
$8K ﹤0.01%
410
– –
JCI icon
212
Johnson Controls International
JCI
$87.5B
$7K ﹤0.01%
143
– –
DFT.PRB
213
DELISTED
DUPONT FABROS TECH INC 7.625% SER B CUMV REDEEM PERP PFD
DFT.PRB
$7K ﹤0.01%
270
-180
-40% -$4.59K
HPQ icon
214
HP
HPQ
$23.5B
$6K ﹤0.01%
500
– –
K
215
DELISTED
Kellanova
K
$6K ﹤0.01%
84
– –
NKE icon
216
Nike
NKE
$61.9B
$6K ﹤0.01%
100
– –
SRCL
217
DELISTED
Stericycle Inc
SRCL
$6K ﹤0.01%
56
– –
COST icon
218
Costco
COST
$415B
$5K ﹤0.01%
31
– –
GS icon
219
Goldman Sachs
GS
$313B
$5K ﹤0.01%
30
– –
IONS icon
220
Ionis Pharmaceuticals
IONS
$9.35B
$5K ﹤0.01%
200
– –
MMM icon
221
3M
MMM
$89B
$5K ﹤0.01%
+35
New +$4.93K
NVO
222
Novo Nordisk
NVO
$216B
$5K ﹤0.01%
200
– –
AFL icon
223
Aflac
AFL
$63.9B
$4K ﹤0.01%
124
– –
EFA icon
224
iShares MSCI EAFE ETF
EFA
$76.4B
$4K ﹤0.01%
+80
New +$4.6K
MZTI
225
The Marzetti Company
MZTI
$2.94B
$4K ﹤0.01%
30
– –
7 8
9
10 11

Similar funds

CRFG
Columbia River Financial Group Vancouver, Washington $172M AUM 13.74% 1-Year Est. Return
TA
Tiptree Advisors New York $172M AUM 86.65% 1-Year Est. Return
BIA
Benchmark Investment Advisors Chicago, Illinois $172M AUM
GWCM
Godshalk Welsh Capital Management Radnor, Pennsylvania $172M AUM 16.03% 1-Year Est. Return
PWM
Peterson Wealth Management Sparks, Nevada $172M AUM 22.85% 1-Year Est. Return
SPF
South Plains Financial Lubbock, Texas $172M AUM 21.06% 1-Year Est. Return
AIG
Abbington Investment Group Westport, Connecticut $172M AUM
NWMG
Nicholson Wealth Management Group Charlestown, South Carolina $172M AUM 10.38% 1-Year Est. Return

Prentiss Smith & Co's Q2 2016 Portfolio in Review

As of Q2 2016, Prentiss Smith & Co held 337 positions worth $178M, up 2.3% from $174M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Prentiss Smith & Co's Q2 2016 filing shows 14 new, 29 increased, 64 reduced and 64 closed positions. Its largest new stake was Williams-Sonoma: 299,928 shares worth $7.82M. The largest sale was Verizon, an estimated $9.75M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Prentiss Smith & Co's largest Q2 2016 buy was Williams-Sonoma: 299,928 shares worth $7.82M.
  • Prentiss Smith & Co added most to Abbott in Q2 2016, an estimated $6.56M increase.
  • Prentiss Smith & Co's biggest Q2 2016 reduction was Verizon, cutting an estimated $9.75M.
  • Prentiss Smith & Co fully exited Praxair Inc in Q2 2016, selling an estimated $791K.
  • Prentiss Smith & Co's ten largest holdings make up 48% of its $178M portfolio in Q2 2016.
  • Prentiss Smith & Co opened 14 new positions and closed 64 in Q2 2016.
  • Prentiss Smith & Co's portfolio value rose 2.3% quarter-over-quarter to $178M.

Based on Prentiss Smith & Co's 13F filing for Q2 2016, filed 28 Jul 2016.